ACTRN12619000562178已完成未知
RBAC-QoL: Rice bran arabinoxylan compound (RBAC) for the quality of life (QoL) of cancer patients - A randomised pilot feasibility trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 31
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Adult patient with informed consent, diagnosed with Stage II-IV solid organ cancers, maintains adequate major organ function (bone marrow, liver, and kidneys), currently undergoing active systemic therapies.
排除标准
- •Existing mental health conditions that may impede the ability in providing consent; Inability to complete QoL questionnaire with minimal assistance; Pregnant, lactating, or has plan to get pregnant during the period of the trial; Active or prior documented autoimmune or inflammatory disorders within the last five years, except for vitiligo or alopecia, stable hypothyroidism on hormone replacement, and any chronic skin condition that does not require systemic therapy.
研究者
相似试验
进行中（未招募）
不适用
A proof of concept study to test whether talarozole has an effect on hand osteoarthritis in the base of thumb jointOsteoarthritis of the handMusculoskeletal DiseasesArthrosisISRCTN16717773niversity of Oxford44
已完成
不适用
The Effect of an RBAC Supplement (BRM4) on NAFLDNon-Alcoholic Fatty Liver DiseaseNCT02568787University of Miami23
已完成
4 期
Consumption of anthocyanin rich Riceberry rice beverage affects postprandial glycemic response, inflammatory markers and antioxidant status induced by a high carbohydrate and moderate fat meal in overweight/obese meoverweight menobese menRiceberry ricehigh carbohydratemoderate fatoverweight menobese menTCTR20210407001Chulalongkorn University13
已完成
不适用
Comparison of two infusion doses of Rocuronium for adequate muscle relaxation during general anesthesiaCTRI/2018/08/015464Dr L H Hiranandani Hospital100
进行中（未招募）
1 期
ASSOCIATION RITUXIMAB - BENDAMUSTINE - ARACYTINE DANS LE TRAITEMENT DES LYMPHOMES B DIFFUS À GRANDES CELLULES REFRACTAIRES OU EN RECHUTE : ETUDE DE PHASE IIPatients atteints de lymphome B diffus à grandes cellules en rechute ou réfractairesMedDRA version: 19.0Level: LLTClassification code 10012855Term: Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation)System Organ Class: 100000004864EUCTR2015-005837-37-FRCHU CAE78